title: Improving plan quality and consistency by standardization of dose constraints in prostate cancer patients treated with CyberKnife.
abstract: Treatment plans for prostate cancer patients undergoing stereotactic body radiation therapy (SBRT) are often challenging due to the proximity of organs at risk. Today, there are no objective criteria to determine whether an optimal treatment plan has been achieved, and physicians rely on their personal experience to evaluate the plan's quality. In this study, we propose a method for determining rectal and bladder dose constraints achievable for a given patient's anatomy. We expect that this method will improve the overall plan quality and consistency, and facilitate comparison of clinical outcomes across different institutions. The 3D proximity of the organs at risk to the target is quantified by means of the expansion-intersection volume (EIV), which is defined as the intersection volume between the target and the organ at risk expanded by 5 mm. We determine a relationship between EIV and relevant dosimetric parameters, such as the volume of bladder and rectum receiving 75% of the prescription dose (V75%). This relationship can be used to establish institution-specific criteria to guide the treatment planning and evaluation process. A database of 25 prostate patients treated with CyberKnife SBRT is used to validate this approach. There is a linear correlation between EIV and V75% of bladder and rectum, confirming that the dose delivered to rectum and bladder increases with increasing extension and proximity of these organs to the target. This information can be used during the planning stage to facilitate the plan optimization process, and to standardize plan quality and consistency. We have developed a method for determining customized dose constraints for prostate patients treated with robotic SBRT. Although the results are technology specific and based on the experience of a single institution, we expect that the application of this method by other institutions will result in improved standardization of clinical practice.
authors.affiliation: University of California San Francisco. mdescovich@radonc.ucsf.edu.
authors.forename: Martina
authors.initials: M
authors.lastname: Descovich
authors.forename: Mauro
authors.initials: M
authors.lastname: Carrara
authors.forename: Sara
authors.initials: S
authors.lastname: Morlino
authors.forename: Dilini S
authors.initials: DS
authors.lastname: Pinnaduwage
authors.forename: Daniel
authors.initials: D
authors.lastname: Saltiel
authors.forename: Jean
authors.initials: J
authors.lastname: Pouliot
authors.forename: Marc B
authors.initials: MB
authors.lastname: Nash
authors.forename: Emanuele
authors.initials: E
authors.lastname: Pignoli
authors.forename: Riccardo
authors.initials: R
authors.lastname: Valdagni
authors.forename: Mack
authors.initials: M
authors.lastname: Roach
authors.forename: Alexander R
authors.initials: AR
authors.lastname: Gottschalk
mesh_terms: D006801:Humans; D008297:Male; D019047:Phantoms, Imaging; D011467:Prostate / Q000528:radiation effects*; D011471:Prostatic Neoplasms / Q000000981:diagnostic imaging / Q000601:surgery*; D016634:Radiosurgery; D011880:Radiotherapy Planning, Computer-Assisted / Q000592:standards*; D020266:Radiotherapy, Conformal / Q000592:standards*; D050397:Radiotherapy, Intensity-Modulated / Q000592:standards; D012007:Rectum / Q000528:radiation effects*; D014057:Tomography, X-Ray Computed; D001743:Urinary Bladder / Q000528:radiation effects*
references.citation: Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):228-34
references.pmid: 21183287
references.citation: Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):236-46
references.pmid: 18722274
references.citation: Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):751-8
references.pmid: 20207506
references.citation: Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):877-82
references.pmid: 21300474
references.citation: Med Phys. 2012 May;39(5):2708-12
references.pmid: 22559641
references.citation: Tumori. 2011 Jul-Aug;97(4):503-9
references.pmid: 21989441
references.citation: Int J Radiat Oncol Biol Phys. 1996 Jul 15;35(5):1019-25
references.pmid: 8751411
references.citation: Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2):573-9
references.pmid: 12957271
references.citation: Int J Radiat Oncol Biol Phys. 2008 Apr 1;70(5):1588-97
references.pmid: 18374232
references.citation: Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1889-96
references.pmid: 21550182
references.citation: Technol Cancer Res Treat. 2010 Oct;9(5):433-52
references.pmid: 20815415
references.citation: Radiother Oncol. 1998 Jun;47(3):285-92
references.pmid: 9681892
references.citation: Phys Med Biol. 2009 Sep 21;54(18):5359-80
references.pmid: 19687567
references.citation: J Endourol. 2010 May;24(5):865-9
references.pmid: 20433370
references.citation: Med Phys. 2008 May;35(5):2094-103
references.pmid: 18561685
references.citation: Med Phys. 2008 Jun;35(6):2294-9
references.pmid: 18649461